| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $106.6M | +4.4% |
| R&D Expense | $433K | -67.8% |
| SG&A Expense | $87.4M | +18.0% |
| Operating Income | -$46.9M | -5.9% |
| Interest Expense | $14.9M | +22.6% |
| Pre-tax Income | -$70.1M | -23.4% |
| Income Tax | $125K | -66.2% |
| Net Income | -$70.3M | -22.8% |
| EPS (Basic) | -$2.09 | +21.7% |
| EPS (Diluted) | -$2.09 | +21.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.4M | +225.1% |
| Short-term Investments | $82.0M | +108.1% |
| Accounts Receivable | $34.1M | +132.2% |
| Inventory | $6.2M | +2.2% |
| Current Assets | $206.8M | +93.7% |
| Total Assets | $386.2M | +52.0% |
| Current Liabilities | $59.5M | +128.5% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.3M | -343.5% |
| Investing Cash Flow | -$86.6M | -26.7% |
| Financing Cash Flow | $144.1M | +158.9% |
| $201.1M |
| +86.8% |
| Total Liabilities | $291.4M | +81.9% |
| Stockholders' Equity | $94.9M | +0.9% |